Salbutamol vs placebo
Chronic lung disease · preterm infants (< 37 weeks GA) at risk of chronic lung disease
Summary of findings table ‐ Salbutamol showed no clear difference in chronic lung disease at 28 days compared with placebo (low certainty).
1 finding from 1 review
- Inhaled bronchodilators for the prevention and treatment of chronic lung disease in preterm infants 2024 · Cochrane Headline outcomes onlyRR 1.03 [0.78, 1.37]1 study · 173 participantsLow